肝微粒體是體外研究一個化合物的代謝(酶抑制，清除率和代謝鑒定)以及藥物-藥物相互作用的主要工具。通常根據(jù)特定細胞色素酶的活性水平來選擇微粒體。 
        
        
 
齊氏生物提供的肝細胞微粒體，每批產(chǎn)品都經(jīng)過嚴格的制備、檢測，確保批次間穩(wěn)定性，然后于凍存管包裝，10 mg/管；-80℃保存，干冰運輸。


         用途：ADME及藥代動力學(xué)檢測試驗

         種屬：人/大鼠/小鼠/兔/狗/豬/猴 /牛/羊/豚鼠/倉鼠 
        
         規(guī)格：0.5ml   20mg/ml

         運輸：凍存管，干冰運輸。

   
        

        微粒體產(chǎn)品被SCI論文引用（部分）：

1.Metabolism of chicoric acid by rat liver microsomes and bioactivity comparisons of chicoric acid and its metabolites
Q Liu, Y Wang, CX Xiao, W Wu, X Liu - Food & function, 2015 - pubs.rsc.org
… 11–14 Moreover, chicoric acid has showed anti-inflammatory, anti-bacterial, anti-HIV
activities, hypoglycemic and hepatocyte protective properties … Rat liver microsomes
were obtained from CHI Scientific, Inc. (Massachusetts, USA) 

2.Hypoxia-triggered gene therapy: a new drug delivery system to utilize photodynamic-induced hypoxia for synergistic cancer therapy
C Huang, J Zheng, D Ma, N Liu, C Zhu, J Li… - Journal of Materials …, 2018 - pubs.rsc.org
… Rat liver microsomes were purchased from CHI Scientific (Jiangsu China … under hypoxic conditions
(red curve); DDS in the presence of inactive rat liver microsomes and NADPH … 0 represent the
fluorescence intensity of TAMRA after and before rat liver microsome addition under …

附：產(chǎn)品介紹